logo
logo

Botanical Solution Inc. (BSI) Secures $3.3 Million in Funding with Second Round Planned for Spring 2021

Dec 23, 2020•over 4 years ago

Amount Raised

$3 Million

Round Type

seed

DavisBiotechnology

Description

Botanical Solution Inc. (BSI), innovator of sustainable, highly consistent and cost effective Advanced Botanical Materials, has successfully secured $3.3 million in a seed round of funding, and is planning another round of funding for Spring 2021.

Company Information

Company

Botanical Solutions

Location

Davis, California, United States

About

Botanical Solution Inc., a Delaware Corporation, has a proprietary platform for sustainable and improved production of consistent, high quality Advanced Botanical Materials (ABM). ABM-01 is the first ABM produced by the company, based on a plant called Quillaja saponaria. ABM-01 is the active ingredient used in two gold standard products, BSI’s biopesticide Quillibrium® and the vaccine adjuvant QS-21, used in a Shingles blockbuster vaccine, a recently launched RSV vaccine and a Malaria vaccine. The Company has received a widespread industry recognition for innovation, winning the “2023 Best Process Innovation Award” from ICIS Chemical Business, the 2022 “New Biotech Business of the Year Award” from BioProtection Forum and the “2022 Product of the Year Award” from S&P Crop Science. To learn more visit us at www.botanical-solution.com/news

FundzWatch™ Score

69
Medium Activity

Buyer Intent Analysis

Get personalized insights on buying likelihood

Related People